Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme
18 mars 2024 08h55 HE
|
PharmAla Biotech
PharmAla's 50:50 Joint Venture with Vitura Health Limited, Cortexa, announces it is first entity to supply Psilocybin into Authorized Prescriber Scheme
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024: Deals Listed by Company A-Z, Headline Value, Therapeutic Area, and Technology Type
08 mars 2024 07h44 HE
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering.Joint Venture Deals in...
Bioprocess Validation Global Strategic Business Report 2024: Rise of Pharma Contract Manufacturing Present Growth Opportunities for Bioprocess Validation Outsourcing to Emerging Markets
01 mars 2024 06h48 HE
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Bioprocess Validation - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Bioprocess Validation...
Global Marine Biotechnology Strategic Business Report 2024: Market to Reach $13.1 Billion by 2030 - Focus on Biofuels as the Future Energy Security Solution Drives Strong Demand
21 févr. 2024 06h12 HE
|
Research and Markets
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Marine Biotechnology - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Marine Biotechnology Market...
PharmAla Data to be Published in ACS Chemical Neuroscience
20 févr. 2024 08h55 HE
|
PharmAla Biotech
PharmAla's drug discovery data to be published in ACS Chemical Neuroscience; PharmAla presents data at ISRP Conference in New Orleans
Alleo Labs Announces Publication on the Use of Artificial Intelligence in Neuroscience Drug Discovery and Development
07 févr. 2024 11h30 HE
|
Alleo Labs
Alleo Labs, a biotechnology company based in San Francisco, publishes an article on the use of artificial intelligence in neuroscience drug discovery.
Cybrexa Regains Rights to CBX-12
06 févr. 2024 08h00 HE
|
Cybrexa Therapeutics
NEW HAVEN, Conn., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC)...
Sai Life Sciences augments DMPK capabilities to ace large-scale collaborations
01 févr. 2024 04h30 HE
|
SAI LIFE SCIENCES LIMITED
HYDERABAD, India, Feb. 01, 2024 (GLOBE NEWSWIRE) -- To offer global big pharma clients cutting-edge, end-to-end drug metabolism and pharmacokinetics (DMPK) services, Sai Life Sciences, a global...
Global Patient-Derived Xenograft/PDX Model Market Set to Expand with Growing Emphasis on Personalized Medicine and Cancer Research
30 janv. 2024 05h20 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Patient-Derived Xenograft/PDX Model Market by Type (Mice, Rat), Implantation Method (Subcutaneous, Orthotopic), Tumor Type (Respiratory,...
CDMO Market Surges Towards USD 322.7 Billion by 2033 | Analyzing Growth in Pharmaceutical Manufacturing
30 janv. 2024 02h34 HE
|
Market.Us
New York, Jan. 30, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global CDMO market size is forecasted to exceed USD 322.7 Billion by 2033, with a promising CAGR of 7.2% from 2024 to 2033. A...